University of Alabama at Birmingham

136 articles with University of Alabama at Birmingham

• 

  AbbVie, Others Spring Into New Real Estate, Personnel Investments

  4/13/2022

  ​​​​​​​With Spring comes new beginnings, and companies within the biopharmaceutical industry are blossoming with fresh ventures. Here are some of them: 
• 

  Gene Therapy Trials for Sickle Cell Disease Hold Hope for Durable Effects

  3/3/2022

  Recent gene therapy research has created a durable response in terms of producing normally-shaped red blood cells and reducing the pain of sickle cell disease.

• UAB and Mereo Announce Positive Top-line Results from “COSTA” a Phase 1b/2 Trial of Alvelestat (MPH966) in Hospitalized Patients with COVID-19 Respiratory Disease

  12/22/2021

  The University of Alabama at Birmingham (UAB) and Mereo BioPharma Group plc today announced top-line data from a Phase 1b/2 clinical trial evaluating alvelestat, a novel, orally active Neutrophil Elastase (NE) inhibitor in hospitalized COVID-19 Respiratory Disease patients.

• Caris' Precision Oncology Alliance Welcomes The O'Neal Comprehensive Cancer Center at University of Alabama at Birmingham

  8/26/2021

  Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence focused on fulfilling the promise of precision medicine, announced that the O'Neal Comprehensive Cancer Center at the University of Alabama at Birmingham has joined Caris' Precision Oncology Alliance™.

• ResBiotic, Inc. Raises $3M Seed Round and Announces Leadership Team

  4/29/2021

  University of Alabama at Birmingham's biotech startup Resbiotic, Inc. announced a $3M seed round to support the development and commercialization of groundbreaking probiotic formulations for lung health.

• Altimmune and UAB Announce Publication of Compelling Pre-clinical Data for AdCOVID™ Intranasal COVID-19 Vaccine Candidate

  10/12/2020

  Comprehensive analysis shows AdCOVID uniquelystimulates three key immune components: serum neutralizing antibody, T cell responses, and mucosal immunity in the respiratory tract

• Altimmune and the University of Alabama at Birmingham (UAB) Announce Positive Preclinical Results for Intranasal COVID-19 Vaccine Candidate, AdCOVID™

  7/13/2020

  AdCOVID stimulated both strong serum neutralizing activity and potent mucosal immunity (IgA) in the respiratory tract

• Altimmune and the University of Alabama at Birmingham to Collaborate on Development of Single-Dose, Intranasal COVID-19 Vaccine

  3/30/2020

  Altimmune, Inc., a clinical-stage biopharmaceutical company, announced that it is launching a collaboration with the University of Alabama at Birmingham on the development of its single-dose, intranasal COVID-19 vaccine, named AdCOVID.

• Top Contact Lens Experts Dispel Misinformation Regarding Coronavirus / COVID-19 Protections for Contact Lens Wearers

  3/12/2020

  Research scientists in Canada, United Kingdom and United States share guidance on safe wear and handling; thorough hand washing and disinfection compliance are important

• 

  Research Roundup: Mutations Linked to Autism, Protein Coats and Alzheimer’s and More

  5/31/2019

  There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
• 

  Research Roundup: Cancer Metastasis, Marathon Training, Fibromyalgia and More

  5/10/2019

  There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
• 

  Is Klotho the Key to Treating Alzheimer’s and Other Diseases of Aging?

  4/2/2019

  Since Biogen and Tokyo-based Eisai recently reported a massive failure in Alzheimer’s research for their drug aducanumab, scientists and industry watchers are scanning the tea leaves looking for other potential approaches to treating the disease. One that is of interest is a hormone called Klotho.
• 

  November 16 Research Roundup: Obesity and Pancreatic Cancer, the Mighty Mitochondria, and Weightl...

  11/16/2018

  There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.

• CIRCULOGENE’s Molecular Testing Can Potentially Improve Management of Advanced Ovarian Cancer Patients

  6/19/2018

  Independent UAB study demonstrates potential value of company’s molecular testing in noninvasive, serial tracking of genomic changes in treatment-resistant ovarian cancer

• CRISPR Awarded Grant From Friedreich’s Ataxia Research Alliance To Collaborate With University of Alabama at Birmingham On Gene-Edited Treatments For Friedrich’s Ataxia

  10/13/2017

• Study Finds Hackers Could Use Brainwaves To Steal Passwords, University of Alabama at Birmingham Reveals

  6/30/2017

• Tracking Hazardous Chemicals From Fast-Food Wrappers In The Body, University of Alabama at Birmingham Study

  3/30/2017

• University of Alabama at Birmingham Selects MILabs Adaptive U-CT To Expand Its Pulmonary Research

  11/29/2016

• Detecting Parkinson’s Through A Urine Test, University of Alabama at Birmingham Study

  7/8/2016

• Why Do Women Live Longer Than Men? University of Alabama at Birmingham Study

  6/15/2016